Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Equity (2016 - 2025)

Historic Return on Equity for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to 0.3%.

  • Niagen Bioscience's Return on Equity rose 2600.0% to 0.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year increase of 2600.0%. This contributed to the annual value of 0.23% for FY2024, which is 4000.0% up from last year.
  • As of Q3 2025, Niagen Bioscience's Return on Equity stood at 0.3%, which was up 2600.0% from 0.3% recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Return on Equity ranged from a high of 0.3% in Q3 2025 and a low of 1.21% during Q2 2022
  • Moreover, its 5-year median value for Return on Equity was 0.24% (2023), whereas its average is 0.34%.
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by -3600bps in 2022, then surged by 9000bps in 2023.
  • Niagen Bioscience's Return on Equity (Quarter) stood at 0.81% in 2021, then rose by 7bps to 0.75% in 2022, then skyrocketed by 76bps to 0.18% in 2023, then surged by 218bps to 0.21% in 2024, then surged by 43bps to 0.3% in 2025.
  • Its last three reported values are 0.3% in Q3 2025, 0.3% for Q2 2025, and 0.28% during Q1 2025.